Gastroenterology Research and Practice / 2013 / Article / Fig 2

Research Article

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo

Figure 2

Dose-related cytotoxicity following 72 h exposured to sorafenib. The IC50 of sorafenib was indicated by the intersection of the plotted line. Sorafenib was 31 μM.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.